Анджела Маас - Женское сердце. Современный подход к здоровью женщин
- Название:Женское сердце. Современный подход к здоровью женщин
- Автор:
- Жанр:
- Издательство:Манн, Иванов и Фербер
- Год:2021
- Город:Москва
- ISBN:978-5-00169-813-5
- Рейтинг:
- Избранное:Добавить в избранное
-
Отзывы:
-
Ваша оценка:
Анджела Маас - Женское сердце. Современный подход к здоровью женщин краткое содержание
Для всех, кто хочет получить актуальную, научно обоснованную информацию о том, как позаботиться о себе и своих близких и на какие факторы риска обращать внимание, чтобы предотвратить проблемы со здоровьем.
Книга подготовлена в информационных целях. Перед применением приведенных рекомендаций обязательно проконсультируйтесь с врачом.
На русском языке публикуется впервые.
Женское сердце. Современный подход к здоровью женщин - читать онлайн бесплатно ознакомительный отрывок
Интервал:
Закладка:
100
National Institute for Health and Care Excellence. Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease // National Clinical Guideline Centre, 2014. URL: www.nice.org.uk/guidance/cg181/evidence/lipid-modification-update-appendices-pdf-243786638(accessed 4th August 2020).
101
Cholesterol treatment trialists, Fulcher J., O’Connell R., Voysey M., Emberson J., Blackwell L. et al. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomized trials // Lancet, 2015. — № 385 (9976). — P. 1397–1405.
102
Thompson P. D., Panza G., Zaleski A. et al. Statin-associated side effects // J Am Coll Cardiol, 2016. — № 67 (20). — P. 2395–2410.
103
Vonbank A., Agewall S., Kjeldsen K. P. et al. Comprehensive efforts to increase adherence to statin therapy // Eur Heart J, 2017. — № 38. — P. 2473–2477.
104
Rosano G. M., Lewis B., Agewall S. et al. Gender differences in the effects of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC // Eur Heart J, 2015. — № 36 (40). — P. 2677–2680.
105
Qu H., Guo M., Chai H. et al. Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials // J Am Heart Assoc, 2018. — № 7. — e009835.
106
Nielsen S. F., Nordestgaard B. G. Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study // Eur Heart J, 2016. — № 37 (11). — P. 908–916.
107
Brouwers JRBJ, Roeters van Lennep JE, Maas AHEM. Rode gist rijst als cholesterolverlager? Een waarschuwing is op zijn plaats // Ned Tijdschr Geneeskd, 2016. — № 160. — D99. (Red yeast rice as cholesterol lowering product? A warning is in order.)
108
Trimarco B., Benvenuti C., Rozza F. et al. Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet // Med J Nutrition Metab, 2011. — № 4 (2). — P. 133–139.
109
Kautzky-Willer A., Handisurya A. Metabolic diseases and associated complications: sex and gender matter! // Eur J Clin Invest, 2009. — № 39 (8). — P. 631–648.
110
Chow C. K., Islam S., Bautista L. et al. Parental history and myocardial infarction risk across the world: the INTERHEART study // J Am Coll Cardiol, 2011. — № 57 (5). — P. 619–627.
111
Mulders T. A., Taraboanta C., Franken L. C. et al. Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease // Atherosclerosis, 2016. — № 245. — P. 155–160.
112
Miller V. N. M., Duckles S. P. Vascular actions of estrogens: functional implications // Pharmacol Rev, 2008. — № 60 (2). — P. 210–241.
113
Muka T., Oliver-Williams C., Kunutsor S. et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis // JAMA Cardiol, 2016. — № 1 (7). — P. 767–776.
114
Rees M., Angioli R., Coleman R. L., Glasspool R., Plotti F., Simoncini T. et al. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis // Maturitas, 2020. — № 134. — P. 56–61.
115
Thurston R. C. Vasomotor symptoms: natural history, physiology, and links with cardiovascular health // Climacteric, 2018. — № 21 (2). — P. 96–100.
116
Thurston R. C., Karvonen-Gutierrez C. A., Derby C. A. et al. Menopause versus chronologic aging: their roles in women’s health // Menopause, 2018. — № 25 (8). — P. 849–854.
117
Vongpatanasin W. Autonomic regulation of blood pressure in menopause // Semin Reprod Med, 2009. — № 27 (4). — P. 338–345.
118
Shufelt C. L., Bairey Merz C. N. Contraceptive hormone use and cardiovascular disease // J Am Coll Cardiol, 2009. — № 53 (3). — P. 221–231.
119
Bassuk S. S., Manson J. E. Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes // Annals of Epidemiology, 2015. — № 25 (3). — P. 193–200.
120
Maas A. H., Euler Mv., Bongers M. Y. et al. Practice points in gynecardiology: abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy // Maturitas, 2015. — № 82 (4). — P. 355–359.
121
Rossouw J. E., Anderson G. L., Prentice R. L. et al. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial // JAMA, 2002. — № 288 (3). — P. 321–333.
122
Neves ECNM, Birkhauser M., Samsioe G. et al. EMAS position statement: the ten point guide to the integral management of menopausal health // Maturitas, 2015. — № 81 (1). — P. 88–92.
123
Mintziori G., Lambrinoudaki I., Goulis D. G. et al. EMAS position statement: non-hormonal management of menopausal vasomotor symptoms // Maturitas, 2015. — № 81 (3). — P. 410–413.
124
Canoy D., Beral V., Balkwill A. et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort // Circulation, 2015. — № 131. — P. 237–244.
125
He C., Murabito J. M. Genome-wide association studies of age at menarche and age at natural menopause // Mol Cell Endocrinol, 2014. — № 382 (1). — P. 767–779.
126
Mu F., Rich-Edwards J., Rimm E. B. et al. Endometriosis and risk of coronary heart disease // Circ Cardiovasc Qual Outcomes, 2016. — № 9 (3). — P. 257–264.
127
Fauser BCJM, Tarlatzis B. C., Rebar R. W. et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group // Fertil Steril, 2012. — № 97. — P. 28–38.
128
Heida K. Y., Bots M. L., de Groot C. J. M. et al. Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline // Eur J Prev Cardiol, 2016. — № 23 (17). — P. 1863–1879.
129
Ingelsson E., Lundholm C., Johansson A. L. et al. Hysterectomy and risk of cardiovascular disease: a population-based cohort study // Eur Heart J, 2011. — № 32 (6). — P. 745–750.
130
Kurth T., Winter A. C., Eliassen A. H. et al. Migraine and risk of cardiovascular disease in women: prospective cohort study // BMJ, 2016. — № 353. — i2610.
131
Van Hemert S., Breedveld A. C., Rovers J. M. et al. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications // Front Neurol, 2014. — № 5. — P. 241.
132
Ranthe M. F., Diaz L. J., Behrens I. et al. Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort study // Eur Heart J, 2016. — № 37 (11). — P. 900–907.
133
Auger N., Fraser W. D., Healy-Profitós J., Arbour L. Association between preeclampsia and congenital heart defects // JAMA, 2015. — № 314 (15). — P. 1588–1598.
134
Zoet G. A., Benschop L., Boersma E. et al. Prevalence of subclinical coronary artery disease assessed by coronary computed tomography angiography in 45- to 55-year-old women with a history of preeclampsia // Circulation, 2018. — № 137 (8). — P. 877–879.
135
Aukes A. M., De Groot J. C., Wiegman M. J. et al. Long-term cerebral imaging after preeclampsia // BJOG, 2012 (Aug). — № 119 (9). — P. 1117–1122.
136
Heida K. Y., Franx A., van Rijn B. B. et al. Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus // Hypertension, 2015. — № 66 (6). — P. 1116–1122.
137
Elias-Smale S. E., Günal A., Maas A. H. Gynecardiology: Distinct patterns of ischemic heart disease in middle-aged women // Maturitas, 2015. — № 81 (3). — P. 348–352.
138
Mason J. C., Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions // Eur Heart J, 2015. — № 36 (8). — P. 482–9c.
139
Bano A., Dhana K., Chaker L. et al. Association of thyroid function with life expectancy with and without cardiovascular disease: The Rotterdam Study // JAMA Intern Med, 2017. — № 177 (11). — P. 1650–1657.
140
Parikh N. I., Jeppson R. P., Berger J. S. et al. Reproductive risk factors and coronary heart disease in the Women’s Health Initiative Observational study // Circulation, 2016. — № 133 (22). — P. 2149–2158.
141
Tuzcu E. M., Kapadia S. R., Tutar E. et al. High Prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound // Circulation, 2001. — № 103. — P. 2705–2710.
142
Claudio C. P., Quesada O., Pepine C. J., Bairey Merz C. N. Why names matter for women: MINOCA/INOCA (Myocardial infarction/ ischemia and no obstructive coronary artery disease) // Clinical Cardiology, 2018. — № 41. — P. 185–193.
143
Johnston N., Schenck-Gustafsson K., Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? // Eur Heart J, 2011. — № 32 (11). — P. 1331–1336.
144
Jespersen L., Hvelplund A., Abildstrom S. Z. et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events // Eur Heart J, 2012. — № 33 (6). — P. 734–744.
145
Sedlak T. L., Lee M., Izadnegahdar M. et al. Sex differences in clinical outcomes in patients with stable angina and no obstructive obstructive coronary artery disease // Am Heart J, 2013. — № 166 (1). — P. 38–44.
Читать дальшеИнтервал:
Закладка:
